| 0 |
CD19 EXPRESSION DECREASED |
1 |
0.3333 |
| 1 |
CD19 ANTIGEN LOSS |
2 |
0.1250 |
| 2 |
BLASTOCYSTIS INFECTION |
5 |
0.0575 |
| 3 |
DIALYSIS DISEQUILIBRIUM SYNDROME |
1 |
0.0500 |
| 4 |
TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY |
1 |
0.0400 |
| 5 |
COR PULMONALE CHRONIC |
6 |
0.0319 |
| 6 |
CSF LYMPHOCYTE COUNT ABNORMAL |
1 |
0.0278 |
| 7 |
CATHETER SITE THROMBOSIS |
7 |
0.0255 |
| 8 |
RHODOCOCCUS INFECTION |
4 |
0.0241 |
| 9 |
FULL BLOOD COUNT |
1 |
0.0175 |
| 10 |
CITROBACTER TEST POSITIVE |
1 |
0.0152 |
| 11 |
TUMOUR FLARE |
9 |
0.0132 |
| 12 |
LYMPHOCYTIC LYMPHOMA |
1 |
0.0120 |
| 13 |
C-REACTIVE PROTEIN DECREASED |
7 |
0.0107 |
| 14 |
LYMPHOMA |
165 |
0.0107 |
| 15 |
BACTERIAL DISEASE CARRIER |
7 |
0.0096 |
| 16 |
BLOOD LACTATE DEHYDROGENASE DECREASED |
3 |
0.0090 |
| 17 |
INCARCERATED INGUINAL HERNIA |
1 |
0.0082 |
| 18 |
FOLLICULAR LYMPHOMA |
7 |
0.0080 |
| 19 |
INFESTATION |
2 |
0.0077 |
| 20 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED |
9 |
0.0072 |
| 21 |
DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV |
2 |
0.0061 |
| 22 |
DIFFUSE LARGE B-CELL LYMPHOMA |
42 |
0.0054 |
| 23 |
DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY |
5 |
0.0053 |
| 24 |
PNEUMONIA ADENOVIRAL |
1 |
0.0051 |
| 25 |
ENTEROCOCCAL BACTERAEMIA |
5 |
0.0047 |
| 26 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
10 |
0.0045 |
| 27 |
TOXIC CARDIOMYOPATHY |
1 |
0.0045 |
| 28 |
B-CELL SMALL LYMPHOCYTIC LYMPHOMA |
1 |
0.0043 |
| 29 |
MEAN ARTERIAL PRESSURE DECREASED |
1 |
0.0040 |
| 30 |
HYPERCALCAEMIA OF MALIGNANCY |
1 |
0.0037 |
| 31 |
PYOMYOSITIS |
1 |
0.0034 |
| 32 |
RETROPERITONEAL ABSCESS |
1 |
0.0032 |
| 33 |
DISCONTINUED PRODUCT ADMINISTERED |
1 |
0.0030 |
| 34 |
BLOOD CREATININE DECREASED |
9 |
0.0029 |
| 35 |
TONGUE EXFOLIATION |
1 |
0.0028 |
| 36 |
SYSTEMIC CANDIDA |
7 |
0.0028 |
| 37 |
LYMPHOMA TRANSFORMATION |
1 |
0.0028 |
| 38 |
ADMINISTRATION SITE REACTION |
1 |
0.0026 |
| 39 |
POLYNEUROPATHY |
29 |
0.0024 |
| 40 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
38 |
0.0024 |
| 41 |
METASTASES TO MENINGES |
5 |
0.0022 |
| 42 |
CREATININE RENAL CLEARANCE ABNORMAL |
1 |
0.0022 |
| 43 |
CYTOPENIA |
26 |
0.0021 |
| 44 |
LONG QT SYNDROME |
5 |
0.0021 |
| 45 |
DISEASE PROGRESSION |
239 |
0.0020 |
| 46 |
HEPATITIS B |
12 |
0.0020 |
| 47 |
METASTASES TO KIDNEY |
1 |
0.0018 |
| 48 |
MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED |
1 |
0.0018 |
| 49 |
LEFT VENTRICULAR FAILURE |
6 |
0.0017 |
| 50 |
LYMPHATIC DISORDER |
1 |
0.0017 |
| 51 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
7 |
0.0016 |
| 52 |
IMMUNISATION REACTION |
1 |
0.0014 |
| 53 |
COMA HEPATIC |
1 |
0.0013 |
| 54 |
CARDIAC DYSFUNCTION |
5 |
0.0013 |
| 55 |
BLOOD FIBRINOGEN INCREASED |
1 |
0.0013 |
| 56 |
PELVIC MASS |
1 |
0.0012 |
| 57 |
ANAL ULCER |
1 |
0.0012 |
| 58 |
PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL |
1 |
0.0012 |
| 59 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
7 |
0.0012 |
| 60 |
ABDOMINAL LYMPHADENOPATHY |
1 |
0.0012 |
| 61 |
PULMONARY FUNCTION TEST DECREASED |
5 |
0.0011 |
| 62 |
INTRACRANIAL MASS |
1 |
0.0011 |
| 63 |
HAEMATOTOXICITY |
10 |
0.0011 |
| 64 |
NEUTROPENIC INFECTION |
1 |
0.0010 |
| 65 |
HEPATITIS C |
12 |
0.0010 |
| 66 |
TUMOUR PSEUDOPROGRESSION |
1 |
0.0009 |
| 67 |
UROSEPSIS |
8 |
0.0009 |
| 68 |
TONGUE HAEMORRHAGE |
1 |
0.0009 |
| 69 |
COVID-19 PNEUMONIA |
10 |
0.0008 |
| 70 |
BLADDER DISCOMFORT |
1 |
0.0008 |
| 71 |
PATHOLOGICAL FRACTURE |
4 |
0.0008 |
| 72 |
OBSTRUCTION GASTRIC |
1 |
0.0008 |
| 73 |
BRONCHOPULMONARY ASPERGILLOSIS |
6 |
0.0008 |
| 74 |
BACTERAEMIA |
9 |
0.0008 |
| 75 |
CYTOKINE RELEASE SYNDROME |
15 |
0.0007 |
| 76 |
CARDIOMYOPATHY |
11 |
0.0007 |
| 77 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
1 |
0.0007 |
| 78 |
CYTOMEGALOVIRUS INFECTION |
12 |
0.0007 |
| 79 |
THROMBOTIC MICROANGIOPATHY |
7 |
0.0007 |
| 80 |
PERIPHERAL ARTERY OCCLUSION |
1 |
0.0007 |
| 81 |
FEBRILE BONE MARROW APLASIA |
3 |
0.0007 |
| 82 |
CONNECTIVE TISSUE DISORDER |
1 |
0.0007 |
| 83 |
INSULIN-LIKE GROWTH FACTOR INCREASED |
1 |
0.0007 |
| 84 |
HEPATIC LESION |
3 |
0.0007 |
| 85 |
NOROVIRUS INFECTION |
1 |
0.0007 |
| 86 |
PULMONARY SEPSIS |
1 |
0.0007 |
| 87 |
ENTEROCOLITIS HAEMORRHAGIC |
1 |
0.0007 |
| 88 |
PARAINFLUENZAE VIRUS INFECTION |
1 |
0.0007 |
| 89 |
HYPERTHERMIA |
5 |
0.0007 |
| 90 |
PERFORMANCE STATUS DECREASED |
3 |
0.0006 |
| 91 |
EPSTEIN-BARR VIRUS INFECTION |
4 |
0.0006 |
| 92 |
AORTIC VALVE DISEASE |
1 |
0.0006 |
| 93 |
LIVER ABSCESS |
2 |
0.0006 |
| 94 |
SPLENIC RUPTURE |
1 |
0.0006 |
| 95 |
MALIGNANT PLEURAL EFFUSION |
1 |
0.0006 |
| 96 |
ACUTE SINUSITIS |
1 |
0.0006 |
| 97 |
OTORRHOEA |
1 |
0.0006 |
| 98 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 99 |
NEOPLASM PROGRESSION |
19 |
0.0005 |
| 100 |
SMALL INTESTINAL PERFORATION |
1 |
0.0005 |
| 101 |
NASAL OBSTRUCTION |
1 |
0.0005 |
| 102 |
METASTASES TO LUNG |
6 |
0.0005 |
| 103 |
EXTRAVASATION |
2 |
0.0005 |
| 104 |
HYPERCALCAEMIA |
6 |
0.0005 |
| 105 |
GASTROENTERITIS |
7 |
0.0005 |
| 106 |
EAR SWELLING |
1 |
0.0005 |
| 107 |
HYPERPHOSPHATAEMIA |
1 |
0.0005 |
| 108 |
HYPOGAMMAGLOBULINAEMIA |
3 |
0.0005 |
| 109 |
TONGUE BLISTERING |
1 |
0.0004 |
| 110 |
CARDIOTOXICITY |
4 |
0.0004 |
| 111 |
LYMPHOEDEMA |
3 |
0.0004 |
| 112 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 113 |
WEIGHT ABNORMAL |
1 |
0.0004 |
| 114 |
HAEMATOLOGICAL INFECTION |
1 |
0.0004 |
| 115 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
2 |
0.0004 |
| 116 |
HEPATOSPLENOMEGALY |
1 |
0.0004 |
| 117 |
PRODUCT ADMINISTRATION INTERRUPTED |
3 |
0.0004 |
| 118 |
ILL-DEFINED DISORDER |
23 |
0.0004 |
| 119 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 120 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 121 |
ABDOMINAL MASS |
1 |
0.0004 |
| 122 |
MALIGNANT NEOPLASM PROGRESSION |
38 |
0.0004 |
| 123 |
CHOLECYSTITIS INFECTIVE |
1 |
0.0004 |
| 124 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 125 |
NECK MASS |
1 |
0.0004 |
| 126 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 127 |
ATYPICAL PNEUMONIA |
1 |
0.0003 |
| 128 |
PNEUMONITIS |
9 |
0.0003 |
| 129 |
THERAPEUTIC RESPONSE CHANGED |
2 |
0.0003 |
| 130 |
LOOSE TOOTH |
1 |
0.0003 |
| 131 |
INCORRECT DISPOSAL OF PRODUCT |
1 |
0.0003 |
| 132 |
SUSPECTED COVID-19 |
1 |
0.0003 |
| 133 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 134 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
1 |
0.0003 |
| 135 |
BLOOD CREATININE ABNORMAL |
1 |
0.0003 |
| 136 |
DEPRESSION SUICIDAL |
1 |
0.0003 |
| 137 |
NEUTROPENIA |
39 |
0.0003 |
| 138 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 139 |
PANCYTOPENIA |
15 |
0.0003 |
| 140 |
GINGIVAL DISORDER |
1 |
0.0003 |
| 141 |
SPINAL CORD COMPRESSION |
1 |
0.0003 |
| 142 |
PNEUMONIA FUNGAL |
1 |
0.0003 |
| 143 |
GALLBLADDER OPERATION |
1 |
0.0002 |
| 144 |
RECURRENT CANCER |
1 |
0.0002 |
| 145 |
HYPERURICAEMIA |
1 |
0.0002 |
| 146 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 147 |
GASTRIC CANCER |
6 |
0.0002 |
| 148 |
ABSCESS LIMB |
1 |
0.0002 |
| 149 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 150 |
LEUKOPENIA |
11 |
0.0002 |
| 151 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 152 |
INFUSION RELATED REACTION |
14 |
0.0002 |
| 153 |
MUSCULOSKELETAL DISORDER |
4 |
0.0002 |
| 154 |
HUMERUS FRACTURE |
1 |
0.0002 |
| 155 |
THERAPY CHANGE |
2 |
0.0002 |
| 156 |
INFLAMMATORY MARKER INCREASED |
1 |
0.0002 |
| 157 |
DRUG TOLERANCE |
1 |
0.0002 |
| 158 |
NEUTROPHIL COUNT DECREASED |
8 |
0.0002 |
| 159 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 160 |
OFF LABEL USE |
168 |
0.0002 |
| 161 |
THERAPY NON-RESPONDER |
8 |
0.0002 |
| 162 |
RALES |
1 |
0.0002 |
| 163 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 164 |
COVID-19 |
30 |
0.0002 |
| 165 |
C-REACTIVE PROTEIN INCREASED |
6 |
0.0002 |
| 166 |
CARDIAC FAILURE |
13 |
0.0002 |
| 167 |
SEPSIS |
18 |
0.0002 |
| 168 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 169 |
WHITE BLOOD CELL COUNT ABNORMAL |
1 |
0.0002 |
| 170 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 171 |
DEAFNESS |
4 |
0.0002 |
| 172 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 173 |
ASPERGILLUS INFECTION |
1 |
0.0002 |
| 174 |
INFECTION |
22 |
0.0002 |
| 175 |
APPETITE DISORDER |
1 |
0.0002 |
| 176 |
INTENTIONAL PRODUCT USE ISSUE |
13 |
0.0001 |
| 177 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 178 |
PLEURAL EFFUSION |
9 |
0.0001 |
| 179 |
NEUROPATHY PERIPHERAL |
14 |
0.0001 |
| 180 |
PRODUCT USE ISSUE |
27 |
0.0001 |
| 181 |
LYMPHOPENIA |
2 |
0.0001 |
| 182 |
LYMPHADENOPATHY |
5 |
0.0001 |
| 183 |
METASTASIS |
1 |
0.0001 |
| 184 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 185 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 186 |
MYELODYSPLASTIC SYNDROME |
2 |
0.0001 |
| 187 |
LABORATORY TEST ABNORMAL |
4 |
0.0001 |
| 188 |
BLOOD COUNT ABNORMAL |
2 |
0.0001 |
| 189 |
ASPARTATE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 190 |
GENERAL PHYSICAL HEALTH DETERIORATION |
15 |
0.0001 |
| 191 |
PULMONARY EMBOLISM |
12 |
0.0001 |
| 192 |
HICCUPS |
1 |
0.0001 |
| 193 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 194 |
GENERALISED TONIC-CLONIC SEIZURE |
2 |
0.0001 |
| 195 |
EMBOLISM |
1 |
0.0001 |
| 196 |
SECOND PRIMARY MALIGNANCY |
1 |
0.0001 |
| 197 |
CANDIDA INFECTION |
2 |
0.0001 |
| 198 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 199 |
THROMBOCYTOPENIA |
13 |
0.0001 |
| 200 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 201 |
RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 202 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 203 |
ALANINE AMINOTRANSFERASE INCREASED |
7 |
0.0001 |
| 204 |
GROIN PAIN |
1 |
0.0001 |
| 205 |
TUMOUR LYSIS SYNDROME |
1 |
0.0001 |
| 206 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 207 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 208 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 209 |
TREATMENT FAILURE |
9 |
0.0001 |
| 210 |
MENTAL STATUS CHANGES |
3 |
0.0001 |
| 211 |
BACTERIAL INFECTION |
2 |
0.0001 |
| 212 |
OEDEMA PERIPHERAL |
13 |
0.0001 |
| 213 |
FEBRILE NEUTROPENIA |
7 |
0.0001 |
| 214 |
DISEASE RECURRENCE |
5 |
0.0001 |
| 215 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
1 |
0.0001 |
| 216 |
TOXIC SKIN ERUPTION |
1 |
0.0001 |
| 217 |
FULL BLOOD COUNT DECREASED |
2 |
0.0001 |
| 218 |
PLATELET COUNT DECREASED |
10 |
0.0001 |
| 219 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 220 |
DISTURBANCE IN ATTENTION |
5 |
0.0001 |
| 221 |
INTERNAL HAEMORRHAGE |
1 |
0.0001 |
| 222 |
MYOCARDITIS |
1 |
0.0001 |
| 223 |
ACUTE KIDNEY INJURY |
13 |
0.0001 |
| 224 |
ATAXIA |
1 |
0.0001 |
| 225 |
CHOLECYSTITIS |
1 |
0.0001 |
| 226 |
WHITE BLOOD CELL COUNT DECREASED |
9 |
0.0001 |
| 227 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 228 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 229 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 230 |
TENDON RUPTURE |
1 |
0.0001 |
| 231 |
PYREXIA |
28 |
0.0001 |
| 232 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 233 |
DEEP VEIN THROMBOSIS |
5 |
0.0001 |
| 234 |
DEATH |
66 |
0.0001 |
| 235 |
TOOTH INFECTION |
1 |
0.0001 |
| 236 |
HYPOTENSION |
15 |
0.0001 |
| 237 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 238 |
MASS |
1 |
0.0001 |
| 239 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 240 |
ANOSMIA |
1 |
0.0001 |
| 241 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 242 |
PNEUMONIA |
22 |
0.0001 |
| 243 |
RENAL FAILURE |
9 |
0.0001 |
| 244 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 245 |
INSURANCE ISSUE |
1 |
0.0001 |
| 246 |
LIMB DISCOMFORT |
2 |
0.0001 |
| 247 |
ASTHENIA |
24 |
0.0001 |
| 248 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 249 |
HIP FRACTURE |
2 |
0.0001 |
| 250 |
ATRIAL FIBRILLATION |
6 |
0.0001 |
| 251 |
METASTASES TO BONE |
1 |
0.0001 |
| 252 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 253 |
RENAL IMPAIRMENT |
5 |
0.0001 |
| 254 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 255 |
PRODUCT DOSE OMISSION ISSUE |
17 |
0.0001 |
| 256 |
HAEMORRHAGE |
6 |
0.0001 |
| 257 |
EOSINOPHILIA |
1 |
0.0001 |
| 258 |
HYPERKALAEMIA |
2 |
0.0001 |
| 259 |
HYPOXIA |
2 |
0.0001 |
| 260 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
1 |
0.0001 |
| 261 |
DRUG ERUPTION |
1 |
0.0001 |
| 262 |
MYELOSUPPRESSION |
2 |
0.0001 |
| 263 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
3 |
0.0001 |
| 264 |
DYSURIA |
2 |
0.0001 |
| 265 |
AGRANULOCYTOSIS |
1 |
0.0001 |
| 266 |
CARDIAC DISORDER |
5 |
0.0001 |
| 267 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 268 |
DRUG INTOLERANCE |
5 |
0.0001 |
| 269 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 270 |
BONE PAIN |
3 |
0.0001 |
| 271 |
KIDNEY INFECTION |
1 |
0.0001 |
| 272 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 273 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 274 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 275 |
HAEMOGLOBIN DECREASED |
5 |
0.0000 |
| 276 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 277 |
ANAEMIA |
9 |
0.0000 |
| 278 |
EATING DISORDER |
1 |
0.0000 |
| 279 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 280 |
CONSTIPATION |
10 |
0.0000 |
| 281 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 282 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 283 |
LIVER DISORDER |
2 |
0.0000 |
| 284 |
TOOTH DISORDER |
1 |
0.0000 |
| 285 |
NEOPLASM MALIGNANT |
3 |
0.0000 |
| 286 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 287 |
RASH |
19 |
0.0000 |
| 288 |
DIARRHOEA |
28 |
0.0000 |
| 289 |
HYPOKALAEMIA |
2 |
0.0000 |
| 290 |
CONFUSIONAL STATE |
7 |
0.0000 |
| 291 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 292 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
0.0000 |
| 293 |
LOCALISED INFECTION |
1 |
0.0000 |
| 294 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 295 |
CELLULITIS |
2 |
0.0000 |
| 296 |
COUGH |
11 |
0.0000 |
| 297 |
ILLNESS |
4 |
0.0000 |
| 298 |
ABDOMINAL PAIN |
9 |
0.0000 |
| 299 |
HAEMATOMA |
1 |
0.0000 |
| 300 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 301 |
ARTHRITIS |
3 |
0.0000 |
| 302 |
RASH PRURITIC |
2 |
0.0000 |
| 303 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 304 |
HAEMOPTYSIS |
1 |
0.0000 |
| 305 |
DEMENTIA |
1 |
0.0000 |
| 306 |
DRUG INEFFECTIVE |
47 |
0.0000 |
| 307 |
BLISTER |
2 |
0.0000 |
| 308 |
HYPONATRAEMIA |
2 |
0.0000 |
| 309 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 310 |
ANGINA PECTORIS |
1 |
0.0000 |
| 311 |
DYSSTASIA |
1 |
0.0000 |
| 312 |
CHILLS |
4 |
0.0000 |
| 313 |
ASCITES |
1 |
0.0000 |
| 314 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 315 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 316 |
RENAL INJURY |
1 |
0.0000 |
| 317 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 318 |
STOMATITIS |
2 |
0.0000 |
| 319 |
DISCOMFORT |
2 |
0.0000 |
| 320 |
MUSCLE SPASMS |
6 |
0.0000 |
| 321 |
HOSPITALISATION |
5 |
0.0000 |
| 322 |
WEIGHT DECREASED |
9 |
0.0000 |
| 323 |
FATIGUE |
25 |
0.0000 |
| 324 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 325 |
DYSPHAGIA |
3 |
0.0000 |
| 326 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 327 |
NIGHT SWEATS |
1 |
0.0000 |
| 328 |
BLOOD CREATININE INCREASED |
2 |
0.0000 |
| 329 |
BACK PAIN |
7 |
0.0000 |
| 330 |
SKIN DISORDER |
1 |
0.0000 |
| 331 |
GAIT INABILITY |
1 |
0.0000 |
| 332 |
CEREBROVASCULAR ACCIDENT |
5 |
0.0000 |
| 333 |
HEART RATE DECREASED |
1 |
0.0000 |
| 334 |
PRODUCT USE IN UNAPPROVED INDICATION |
7 |
0.0000 |
| 335 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 336 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 337 |
PANIC ATTACK |
1 |
0.0000 |
| 338 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 339 |
PAIN IN EXTREMITY |
8 |
0.0000 |
| 340 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 341 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 342 |
DECREASED APPETITE |
6 |
0.0000 |
| 343 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 344 |
DISORIENTATION |
1 |
0.0000 |
| 345 |
JOINT SWELLING |
3 |
0.0000 |
| 346 |
CARDIAC ARREST |
2 |
0.0000 |
| 347 |
POLLAKIURIA |
1 |
0.0000 |
| 348 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 349 |
HYPOACUSIS |
1 |
0.0000 |
| 350 |
CONDITION AGGRAVATED |
7 |
0.0000 |
| 351 |
SEPTIC SHOCK |
1 |
0.0000 |
| 352 |
MENTAL DISORDER |
1 |
0.0000 |
| 353 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 354 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 355 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 356 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 357 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 358 |
BREAST CANCER |
2 |
0.0000 |
| 359 |
SWELLING |
2 |
0.0000 |
| 360 |
VOMITING |
10 |
0.0000 |
| 361 |
DYSPNOEA |
12 |
0.0000 |
| 362 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 363 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 364 |
HEADACHE |
13 |
0.0000 |
| 365 |
LUNG DISORDER |
1 |
0.0000 |
| 366 |
NAUSEA |
16 |
0.0000 |
| 367 |
SOMNOLENCE |
4 |
0.0000 |
| 368 |
FLUID RETENTION |
1 |
0.0000 |
| 369 |
THERAPY CESSATION |
1 |
0.0000 |
| 370 |
ARTHRALGIA |
8 |
0.0000 |
| 371 |
ECZEMA |
1 |
0.0000 |
| 372 |
MEDICATION ERROR |
1 |
0.0000 |
| 373 |
INFLUENZA |
2 |
0.0000 |
| 374 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 375 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 376 |
LETHARGY |
1 |
0.0000 |
| 377 |
DYSPHONIA |
1 |
0.0000 |
| 378 |
NASAL CONGESTION |
1 |
0.0000 |
| 379 |
NO ADVERSE EVENT |
3 |
0.0000 |
| 380 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 381 |
CHEST PAIN |
3 |
0.0000 |
| 382 |
DIZZINESS |
8 |
0.0000 |
| 383 |
AMNESIA |
1 |
0.0000 |
| 384 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 385 |
SLEEP DISORDER |
1 |
0.0000 |
| 386 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 387 |
BRONCHITIS |
1 |
0.0000 |
| 388 |
DYSGEUSIA |
1 |
0.0000 |
| 389 |
EPISTAXIS |
1 |
0.0000 |
| 390 |
HYPOAESTHESIA |
2 |
0.0000 |
| 391 |
HALLUCINATION |
1 |
0.0000 |
| 392 |
HOT FLUSH |
1 |
0.0000 |
| 393 |
DEPRESSION |
3 |
0.0000 |
| 394 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 395 |
PRURITUS |
5 |
0.0000 |
| 396 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 397 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 398 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 399 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 400 |
THROMBOSIS |
1 |
0.0000 |
| 401 |
BALANCE DISORDER |
1 |
0.0000 |
| 402 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 403 |
INSOMNIA |
3 |
0.0000 |
| 404 |
TACHYCARDIA |
1 |
0.0000 |
| 405 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 406 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 407 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 408 |
MIGRAINE |
1 |
0.0000 |
| 409 |
CONTUSION |
1 |
0.0000 |
| 410 |
ALOPECIA |
2 |
0.0000 |
| 411 |
HEART RATE INCREASED |
1 |
0.0000 |
| 412 |
FLUSHING |
1 |
0.0000 |
| 413 |
SINUSITIS |
1 |
0.0000 |
| 414 |
ERYTHEMA |
2 |
0.0000 |
| 415 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 416 |
MALAISE |
4 |
0.0000 |
| 417 |
FALL |
3 |
0.0000 |
| 418 |
ASTHMA |
1 |
0.0000 |
| 419 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 420 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 421 |
HYPERHIDROSIS |
1 |
0.0000 |
| 422 |
PSORIASIS |
1 |
0.0000 |
| 423 |
DEHYDRATION |
1 |
0.0000 |
| 424 |
VISION BLURRED |
1 |
0.0000 |
| 425 |
PAIN |
4 |
0.0000 |
| 426 |
TREMOR |
1 |
0.0000 |
| 427 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 428 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 429 |
MYALGIA |
1 |
0.0000 |
| 430 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 431 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 432 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 433 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 434 |
HYPERTENSION |
1 |
0.0000 |
| 435 |
WEIGHT INCREASED |
1 |
0.0000 |
| 436 |
FEELING ABNORMAL |
1 |
0.0000 |